Sequent Scientific Ltd.
| BSE: 512529 | Sector: Health care |
| NSE: SEQUENT | ISIN Code: INE807F01027 |
| BSE 00:00 | 10 Aug | 108.15 |
-16.65 (-13.34%) |
OPEN
111.25 |
HIGH
113.05 |
LOW
106.30 |
| NSE 00:00 | 10 Aug | 108.20 |
-16.60 (-13.30%) |
OPEN
107.85 |
HIGH
113.25 |
LOW
106.85 |
| OPEN | 111.25 |
| PREVIOUS CLOSE | 124.80 |
| VOLUME | 496942 |
| 52-Week high | 295.85 |
| 52-Week low | 81.40 |
| P/E | 183.31 |
| Mkt Cap.(Rs cr) | 2,698 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
About Sequent Scientific Ltd.
Sequent Scientific Ltd
Visistha Traders & Finance Ltd has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12 2003....> More
Sequent Scientific Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
2,698 | |
| EPS - TTM | () |
[*S] | 0.59 |
| P/E Ratio | (X) | [*S] | 183.31 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 25.00 | |
| Latest Dividend Date | 08 Sep 2021 | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 41.75 |
| P/B Ratio | () |
[*S] | 2.59 |
Announcement
-
Board Meeting Outcome for Outcome Of Board Meeting Held On August 08 2022 Along With Unaudited Stand
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations &
-
Statement Of Investor Complaints For The Quarter Ended June 2022
Sequent Scientific Ltd - Financial Results
Particulars ( cr) |
Jun 2022 | Jun 2021 | % Chg |
| Net Sales | 341.32 | 320.51 | 6.49 |
| Other Income | 0.88 | 2.67 | -67.04 |
| Total Income | 342.2 | 323.18 | 5.89 |
| Total Expenses | 342.4 | 300.35 | 14 |
| Operating Profit | -0.2 | 22.83 | -100.88 |
| Net Profit | -14.41 | 2.65 | -643.77 |
| Equity Capital | 49.67 | 49.67 | - |
Sequent Scientific Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Hikal | 257.45 | -1.89 | 3174.36 |
| Strides Pharma | 346.05 | 1.50 | 3107.53 |
| Supriya Lifesci. | 359.15 | 3.16 | 2891.16 |
| Sequent Scien. | 108.15 | -13.34 | 2697.80 |
| Amrutanjan Healt | 815.35 | -1.36 | 2380.82 |
| IOL Chemicals | 348.60 | -1.97 | 2046.63 |
| Marksans Pharma | 50.00 | 0.50 | 2046.50 |
Sequent Scientific Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherSequent Scientific Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -16.13% | -16.09% | 0.80% | 0.84% |
| 1 Month | 2.71% | 2.80% | 7.96% | 8.10% |
| 3 Month | -11.24% | -11.06% | 8.19% | 7.97% |
| 6 Month | -29.50% | -29.14% | -0.18% | -0.40% |
| 1 Year | -61.42% | -61.42% | 7.81% | 7.71% |
| 3 Year | 53.62% | 53.48% | 56.50% | 57.83% |
Sequent Scientific Ltd - STOCK STRENGTH
| Today's Low/High | 106.30 |
|
113.05 |
| Week Low/High | 106.30 |
|
132.00 |
| Month Low/High | 99.50 |
|
132.00 |
| YEAR Low/High | 81.40 |
|
296.00 |
| All TIME Low/High | 0.37 |
|
336.00 |
Quick Links for Sequent Scientific:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
